CD44 and cancer: Dan et al. co-incubated CD44 specific binding ligand hyaluronan with milk-derived exosomes to deliver doxorubicin (DOX) and found that these exosomes could target CD44 positive cancer cells to induce apoptosis (Li D. et al., 2020).